Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...
Clinical Trials Arena on MSN
Non-animal models at inflection point, but hedging expectations crucial
While NAMs could revolutionise preclinical development, experts warn that they won’t phase out animal testing for “a long ...
The U.S. Food and Drug Administration’s recently published Roadmap to Reducing Animal Testing in Preclinical Safety Studies may have caused a stir across the pharmaceutical and biotech industries, but ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of animals each year are killed in U.S. laboratories as part ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on how marketing applicants can use non-animal data in their applications. The move comes on the heels of a ...
The European Food Safety Authority (ESFA) develops a new platform to model and predict the toxicity of chemicals, signalling the potential to end animal testing. Safety assessments to evaluate the ...
The US Food and Drug Administration (FDA) roadmap to reduce animal testing as a requirement for drug development has already made an impact after its first year, but the initiative faces future ...
Around 348 B.C., Aristotle took a two-year trip to the eastern Aegean island of Lesbos to study animals in a lagoon. Along with observing the creatures in their natural habitat and surmising, among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results